Characteristics and outcomes of type 2 myocardial infarction in sepsis survivors
-
By
-
Xiao-ya Ma
-
Mei-xia Ma
-
Yun-yue Luo
-
Hui Wang
-
Yue Li
-
Yu-xin Wang
-
Wu-lin Li
-
Yue Liu
-
Wen-hui Kang
-
Jian-jun Xia
-
Li Wang
-
Fei Wang
-
May 7, 2026
-
Clinical Scorecard: Clinical Features and Prognostic Outcomes of Type 2 Myocardial Infarction in Survivors of Sepsis in the ICU
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Imbalance between myocardial oxygen supply and demand due to factors like hypoxemia, anemia, and other complications of sepsis. |
| Target Population | |
| Care Setting | |
Key Highlights
- T2MI is associated with higher 6-month and 5-year mortality compared to type 1 myocardial infarction (TIMI).
Guideline-Based Recommendations
Diagnosis
Management
- Consider the use of supportive therapies such as oxygen supplementation and fluid management for managing T2MI in sepsis survivors.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with T2MI received fewer medications such as statins and beta-blockers, which may impact long-term cardiovascular outcomes.
Clinical Best Practices
- Identify and manage underlying causes of T2MI, such as anemia and hypoxemia, based on current clinical guidelines.
- Implement a multidisciplinary approach for the care of sepsis survivors, involving cardiology and critical care specialists.
Related Resources & Content
